▶ 調査レポート

高血圧薬の世界市場 2020年:メーカー別、地域別、種類・用途別

• 英文タイトル:Global Hypertension Drug Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。高血圧薬の世界市場 2020年:メーカー別、地域別、種類・用途別 / Global Hypertension Drug Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / D005-08405資料のイメージです。• レポートコード:D005-08405
• 出版社/出版日:GlobalInfoResearch / 2020年5月
• レポート形態:英文、PDF、101ページ
• 納品方法:Eメール(納期2~3日)
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥382,800 (USD3,480)▷ お問い合わせ
  Multi User¥574,200 (USD5,220)▷ お問い合わせ
  Corporate User¥765,600 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、高血圧薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。高血圧薬の種類別市場規模(カルシウムチャンネルブロッカー、利尿薬、ベータ遮断薬血管拡張薬、アンジオテンシン変換酵素阻害剤、アルファブロッカー、アンジオテンシン受容体ブロッカー、レニン阻害剤)、用途別市場規模(病院、私立クリニック、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Lupin Limited、Johnson & Johnson Ltd、Pfizer Inc、Novartis AG、AstraZeneca Plc、Daiichi - Sankyo、Merck & Co.、Sanofi S.A、Ranbaxy Laboratories Limited、Boehringer Ingelheim
・地域別グローバル市場分析 2015年-2020年
・高血圧薬の北米市場(アメリカ、カナダ、メキシコ)
・高血圧薬のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・高血圧薬のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・高血圧薬の南米市場(ブラジル、アルゼンチン)
・高血圧薬の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:カルシウムチャンネルブロッカー、利尿薬、ベータ遮断薬血管拡張薬、アンジオテンシン変換酵素阻害剤、アルファブロッカー、アンジオテンシン受容体ブロッカー、レニン阻害剤
・用途別分析:病院、私立クリニック、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The global Hypertension Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 0.6% in the forecast period of 2020 to 2025 and will expected to reach USD 23440 million by 2025, from USD 22890 million in 2019.

The Hypertension Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Hypertension Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Hypertension Drug market has been segmented into
Calcium Channel Blockers
Diuretics
Beta Blockers Vasodilators
Angiotensin Converting Enzyme Inhibitors
Alpha Blockers
Angiotensin Receptor Blockers
Renin Inhibitors

By Application, Hypertension Drug has been segmented into:
Hospital
Private clinic
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Hypertension Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Hypertension Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Hypertension Drug market.

The report offers in-depth assessment of the growth and other aspects of the Hypertension Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Hypertension Drug Market Share Analysis
Hypertension Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Hypertension Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Hypertension Drug sales, revenue and market share for each player covered in this report.

The major players covered in Hypertension Drug are:
Lupin Limited
Johnson & Johnson Ltd
Pfizer Inc
Novartis AG
AstraZeneca Plc
Daiichi – Sankyo
Merck & Co.
Sanofi S.A
Ranbaxy Laboratories Limited
Boehringer Ingelheim

Among other players domestic and global, Hypertension Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hypertension Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Hypertension Drug, with price, sales, revenue and global market share of Hypertension Drug in 2018 and 2019.
Chapter 3, the Hypertension Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hypertension Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Hypertension Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Hypertension Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

Table of Contents

1 Market Overview
1.1 Hypertension Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Hypertension Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Calcium Channel Blockers
1.2.3 Diuretics
1.2.4 Beta Blockers Vasodilators
1.2.5 Angiotensin Converting Enzyme Inhibitors
1.2.6 Alpha Blockers
1.2.7 Angiotensin Receptor Blockers
1.2.8 Renin Inhibitors
1.3 Market Analysis by Application
1.3.1 Overview: Global Hypertension Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Private clinic
1.3.4 Others
1.4 Overview of Global Hypertension Drug Market
1.4.1 Global Hypertension Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Lupin Limited
2.1.1 Lupin Limited Details
2.1.2 Lupin Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Lupin Limited SWOT Analysis
2.1.4 Lupin Limited Product and Services
2.1.5 Lupin Limited Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Johnson & Johnson Ltd
2.2.1 Johnson & Johnson Ltd Details
2.2.2 Johnson & Johnson Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Johnson & Johnson Ltd SWOT Analysis
2.2.4 Johnson & Johnson Ltd Product and Services
2.2.5 Johnson & Johnson Ltd Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Pfizer Inc
2.3.1 Pfizer Inc Details
2.3.2 Pfizer Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Pfizer Inc SWOT Analysis
2.3.4 Pfizer Inc Product and Services
2.3.5 Pfizer Inc Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis AG
2.4.1 Novartis AG Details
2.4.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis AG SWOT Analysis
2.4.4 Novartis AG Product and Services
2.4.5 Novartis AG Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 AstraZeneca Plc
2.5.1 AstraZeneca Plc Details
2.5.2 AstraZeneca Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 AstraZeneca Plc SWOT Analysis
2.5.4 AstraZeneca Plc Product and Services
2.5.5 AstraZeneca Plc Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Daiichi – Sankyo
2.6.1 Daiichi – Sankyo Details
2.6.2 Daiichi – Sankyo Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Daiichi – Sankyo SWOT Analysis
2.6.4 Daiichi – Sankyo Product and Services
2.6.5 Daiichi – Sankyo Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Merck & Co.
2.7.1 Merck & Co. Details
2.7.2 Merck & Co. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Merck & Co. SWOT Analysis
2.7.4 Merck & Co. Product and Services
2.7.5 Merck & Co. Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Sanofi S.A
2.8.1 Sanofi S.A Details
2.8.2 Sanofi S.A Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Sanofi S.A SWOT Analysis
2.8.4 Sanofi S.A Product and Services
2.8.5 Sanofi S.A Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Ranbaxy Laboratories Limited
2.9.1 Ranbaxy Laboratories Limited Details
2.9.2 Ranbaxy Laboratories Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Ranbaxy Laboratories Limited SWOT Analysis
2.9.4 Ranbaxy Laboratories Limited Product and Services
2.9.5 Ranbaxy Laboratories Limited Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Boehringer Ingelheim
2.10.1 Boehringer Ingelheim Details
2.10.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Boehringer Ingelheim SWOT Analysis
2.10.4 Boehringer Ingelheim Product and Services
2.10.5 Boehringer Ingelheim Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Hypertension Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Hypertension Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Hypertension Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Hypertension Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Hypertension Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Hypertension Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Hypertension Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Hypertension Drug Sales and Growth Rate (2015-2020)
4.3 Europe Hypertension Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Hypertension Drug Sales and Growth Rate (2015-2020)
4.5 South America Hypertension Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Hypertension Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Hypertension Drug Sales, Revenue and Market Share by Country
5.1.1 North America Hypertension Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Hypertension Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Hypertension Drug Sales and Growth Rate (2015-2020)
5.3 Canada Hypertension Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Hypertension Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Hypertension Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Hypertension Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Hypertension Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Hypertension Drug Sales and Growth Rate (2015-2020)
6.3 UK Hypertension Drug Sales and Growth Rate (2015-2020)
6.4 France Hypertension Drug Sales and Growth Rate (2015-2020)
6.5 Russia Hypertension Drug Sales and Growth Rate (2015-2020)
6.6 Italy Hypertension Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Hypertension Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Hypertension Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Hypertension Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Hypertension Drug Sales and Growth Rate (2015-2020)
7.3 Japan Hypertension Drug Sales and Growth Rate (2015-2020)
7.4 Korea Hypertension Drug Sales and Growth Rate (2015-2020)
7.5 India Hypertension Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Hypertension Drug Sales and Growth Rate (2015-2020)
7.7 Australia Hypertension Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Hypertension Drug Sales, Revenue and Market Share by Country
8.1.1 South America Hypertension Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Hypertension Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Hypertension Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Hypertension Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Hypertension Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Hypertension Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Hypertension Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Hypertension Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Hypertension Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Hypertension Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Hypertension Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Hypertension Drug Sales and Market Share by Type (2015-2020)
10.2 Global Hypertension Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Hypertension Drug Price by Type (2015-2020)
11 Global Hypertension Drug Market Segment by Application
11.1 Global Hypertension Drug Sales Market Share by Application (2015-2020)
11.2 Global Hypertension Drug Revenue Market Share by Application (2015-2020)
11.3 Global Hypertension Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Hypertension Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Hypertension Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Hypertension Drug Market Forecast (2021-2025)
12.2.2 Europe Hypertension Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Hypertension Drug Market Forecast (2021-2025)
12.2.4 South America Hypertension Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Hypertension Drug Market Forecast (2021-2025)
12.3 Hypertension Drug Market Forecast by Type (2021-2025)
12.3.1 Global Hypertension Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Hypertension Drug Market Share Forecast by Type (2021-2025)
12.4 Hypertension Drug Market Forecast by Application (2021-2025)
12.4.1 Global Hypertension Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Hypertension Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Hypertension Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Hypertension Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Hypertension Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Lupin Limited Basic Information, Manufacturing Base and Competitors
Table 8. Lupin Limited Hypertension Drug Major Business
Table 9. Lupin Limited Hypertension Drug Total Revenue (USD Million) (2017-2018)
Table 10. Lupin Limited SWOT Analysis
Table 11. Lupin Limited Hypertension Drug Product and Services
Table 12. Lupin Limited Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Johnson & Johnson Ltd Basic Information, Manufacturing Base and Competitors
Table 14. Johnson & Johnson Ltd Hypertension Drug Major Business
Table 15. Johnson & Johnson Ltd Hypertension Drug Total Revenue (USD Million) (2017-2018)
Table 16. Johnson & Johnson Ltd SWOT Analysis
Table 17. Johnson & Johnson Ltd Hypertension Drug Product and Services
Table 18. Johnson & Johnson Ltd Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer Inc Hypertension Drug Major Business
Table 21. Pfizer Inc Hypertension Drug Total Revenue (USD Million) (2017-2018)
Table 22. Pfizer Inc SWOT Analysis
Table 23. Pfizer Inc Hypertension Drug Product and Services
Table 24. Pfizer Inc Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 26. Novartis AG Hypertension Drug Major Business
Table 27. Novartis AG Hypertension Drug Total Revenue (USD Million) (2017-2018)
Table 28. Novartis AG SWOT Analysis
Table 29. Novartis AG Hypertension Drug Product and Services
Table 30. Novartis AG Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. AstraZeneca Plc Basic Information, Manufacturing Base and Competitors
Table 32. AstraZeneca Plc Hypertension Drug Major Business
Table 33. AstraZeneca Plc Hypertension Drug Total Revenue (USD Million) (2017-2018)
Table 34. AstraZeneca Plc SWOT Analysis
Table 35. AstraZeneca Plc Hypertension Drug Product and Services
Table 36. AstraZeneca Plc Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Daiichi - Sankyo Basic Information, Manufacturing Base and Competitors
Table 38. Daiichi - Sankyo Hypertension Drug Major Business
Table 39. Daiichi - Sankyo Hypertension Drug Total Revenue (USD Million) (2017-2018)
Table 40. Daiichi - Sankyo SWOT Analysis
Table 41. Daiichi - Sankyo Hypertension Drug Product and Services
Table 42. Daiichi - Sankyo Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 44. Merck & Co. Hypertension Drug Major Business
Table 45. Merck & Co. Hypertension Drug Total Revenue (USD Million) (2017-2018)
Table 46. Merck & Co. SWOT Analysis
Table 47. Merck & Co. Hypertension Drug Product and Services
Table 48. Merck & Co. Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Sanofi S.A Basic Information, Manufacturing Base and Competitors
Table 50. Sanofi S.A Hypertension Drug Major Business
Table 51. Sanofi S.A Hypertension Drug Total Revenue (USD Million) (2017-2018)
Table 52. Sanofi S.A SWOT Analysis
Table 53. Sanofi S.A Hypertension Drug Product and Services
Table 54. Sanofi S.A Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Ranbaxy Laboratories Limited Basic Information, Manufacturing Base and Competitors
Table 56. Ranbaxy Laboratories Limited Hypertension Drug Major Business
Table 57. Ranbaxy Laboratories Limited Hypertension Drug Total Revenue (USD Million) (2017-2018)
Table 58. Ranbaxy Laboratories Limited SWOT Analysis
Table 59. Ranbaxy Laboratories Limited Hypertension Drug Product and Services
Table 60. Ranbaxy Laboratories Limited Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 62. Boehringer Ingelheim Hypertension Drug Major Business
Table 63. Boehringer Ingelheim Hypertension Drug Total Revenue (USD Million) (2017-2018)
Table 64. Boehringer Ingelheim SWOT Analysis
Table 65. Boehringer Ingelheim Hypertension Drug Product and Services
Table 66. Boehringer Ingelheim Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Hypertension Drug Sales by Manufacturer (2018-2019) (K Units)
Table 68. Global Hypertension Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Hypertension Drug Sales by Regions (2015-2020) (K Units)
Table 70. Global Hypertension Drug Sales Market Share by Regions (2015-2020)
Table 71. Global Hypertension Drug Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Hypertension Drug Sales by Countries (2015-2020) (K Units)
Table 73. North America Hypertension Drug Sales Market Share by Countries (2015-2020)
Table 74. North America Hypertension Drug Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Hypertension Drug Revenue Market Share by Countries (2015-2020)
Table 76. Europe Hypertension Drug Sales by Countries (2015-2020) (K Units)
Table 77. Europe Hypertension Drug Sales Market Share by Countries (2015-2020)
Table 78. Europe Hypertension Drug Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Hypertension Drug Sales by Regions (2015-2020) (K Units)
Table 80. Asia-Pacific Hypertension Drug Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Hypertension Drug Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Hypertension Drug Sales by Countries (2015-2020) (K Units)
Table 83. South America Hypertension Drug Sales Market Share by Countries (2015-2020)
Table 84. South America Hypertension Drug Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Hypertension Drug Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Hypertension Drug Sales by Countries (2015-2020) (K Units)
Table 87. Middle East & Africa Hypertension Drug Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Hypertension Drug Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Hypertension Drug Revenue Market Share by Countries (2015-2020)
Table 90. Global Hypertension Drug Sales by Type (2015-2020) (K Units)
Table 91. Global Hypertension Drug Sales Share by Type (2015-2020)
Table 92. Global Hypertension Drug Revenue by Type (2015-2020) (USD Million)
Table 93. Global Hypertension Drug Revenue Share by Type (2015-2020)
Table 94. Global Hypertension Drug Sales by Application (2015-2020) (K Units)
Table 95. Global Hypertension Drug Sales Share by Application (2015-2020)
Table 96. Global Hypertension Drug Sales Forecast by Regions (2021-2025) (K Units)
Table 97. Global Hypertension Drug Market Share Forecast by Regions (2021-2025)
Table 98. Global Hypertension Drug Sales Forecast by Type (2021-2025) (K Units)
Table 99. Global Hypertension Drug Market Share Forecast by Type (2021-2025)
Table 100. Global Hypertension Drug Sales Forecast by Application (2021-2025)
Table 101. Global Hypertension Drug Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Hypertension Drug Picture
Figure 2. Global Sales Market Share of Hypertension Drug by Type in 2019
Figure 3. Calcium Channel Blockers Picture
Figure 4. Diuretics Picture
Figure 5. Beta Blockers Vasodilators Picture
Figure 6. Angiotensin Converting Enzyme Inhibitors Picture
Figure 7. Alpha Blockers Picture
Figure 8. Angiotensin Receptor Blockers Picture
Figure 9. Renin Inhibitors Picture
Figure 10. Hypertension Drug Sales Market Share by Application in 2018
Figure 11. Hospital Picture
Figure 12. Private clinic Picture
Figure 13. Others Picture
Figure 14. Global Hypertension Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 15. United States Hypertension Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Canada Hypertension Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Mexico Hypertension Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Germany Hypertension Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. France Hypertension Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. UK Hypertension Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Russia Hypertension Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Italy Hypertension Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. China Hypertension Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Japan Hypertension Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Korea Hypertension Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. India Hypertension Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Southeast Asia Hypertension Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Australia Hypertension Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 29. Brazil Hypertension Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Egypt Hypertension Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Saudi Arabia Hypertension Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 32. South Africa Hypertension Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Turkey Hypertension Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Global Hypertension Drug Sales Market Share by Manufacturer in 2019
Figure 35. Global Hypertension Drug Revenue Market Share by Manufacturer in 2019
Figure 36. Top 3 Hypertension Drug Manufacturer (Revenue) Market Share in 2019
Figure 37. Top 6 Hypertension Drug Manufacturer (Revenue) Market Share in 2019
Figure 38. Key Manufacturer Market Share Trend
Figure 39. Global Hypertension Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 40. Global Hypertension Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 41. Global Hypertension Drug Revenue Market Share by Regions (2015-2020)
Figure 42. Global Hypertension Drug Revenue Market Share by Regions in 2018
Figure 43. North America Hypertension Drug Sales and Growth Rate (2015-2020)
Figure 44. Europe Hypertension Drug Sales and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Hypertension Drug Sales and Growth Rate (2015-2020)
Figure 46. South America Hypertension Drug Sales and Growth Rate (2015-2020)
Figure 47. Middle East & Africa Hypertension Drug Sales and Growth Rate (2015-2020)
Figure 48. North America Hypertension Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 49. North America Hypertension Drug Sales Market Share by Countries (2015-2020)
Figure 50. North America Hypertension Drug Sales Market Share by Countries in 2018
Figure 51. North America Hypertension Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 52. North America Hypertension Drug Revenue Market Share by Countries in 2018
Figure 53. United States Hypertension Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Canada Hypertension Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 55. Mexico Hypertension Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Europe Hypertension Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 57. Europe Hypertension Drug Revenue Market Share by Countries (2015-2020)
Figure 58. Europe Hypertension Drug Revenue Market Share by Countries in 2019
Figure 59. Germany Hypertension Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 60. UK Hypertension Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 61. France Hypertension Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Russia Hypertension Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Italy Hypertension Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Asia-Pacific Hypertension Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 65. Asia-Pacific Hypertension Drug Sales Market Share by Regions 2019
Figure 66. Asia-Pacific Hypertension Drug Revenue Market Share by Regions 2019
Figure 67. China Hypertension Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Japan Hypertension Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Korea Hypertension Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 70. India Hypertension Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Southeast Asia Hypertension Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 72. South America Hypertension Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. South America Hypertension Drug Sales Market Share by Countries in 2019
Figure 74. South America Hypertension Drug Revenue Market Share by Countries in 2019
Figure 75. Brazil Hypertension Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Argentina Hypertension Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Middle East and Africa Hypertension Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. Middle East and Africa Hypertension Drug Sales Market Share by Countries in 2019
Figure 79. Middle East and Africa Hypertension Drug Revenue Market Share by Countries (2015-2020)
Figure 80. Middle East and Africa Hypertension Drug Revenue Market Share by Countries in 2019
Figure 81. Saudi Arabia Hypertension Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Egypt Hypertension Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Turkey Hypertension Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 84. South Africa Hypertension Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 85. Global Hypertension Drug Sales and Growth Rate (2021-2025) (K Units)
Figure 86. Global Hypertension Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 87. North America Sales Hypertension Drug Market Forecast (2021-2025) (K Units)
Figure 88. Europe Sales Hypertension Drug Market Forecast (2021-2025) (K Units)
Figure 89. Asia-Pacific Sales Hypertension Drug Market Forecast (2021-2025) (K Units)
Figure 90. South America Sales Hypertension Drug Market Forecast (2021-2025) (K Units)
Figure 91. Middle East & Africa Sales Hypertension Drug Market Forecast (2021-2025) (K Units)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel